<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01142479</url>
  </required_header>
  <id_info>
    <org_study_id>TPE-1-breast Ca</org_study_id>
    <nct_id>NCT01142479</nct_id>
  </id_info>
  <brief_title>Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy</brief_title>
  <official_title>The Effects of Compound Herbal Formula(TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei City Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Taipei Medical University Shuang Ho Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Taipei City Hospital</source>
  <brief_summary>
    <textblock>
      Many breast cancer patients will taking Chinese herbal medicine during receiving
      radiotherapy. The investigators conducted the pilot study showing Compound Herbal Formula
      (TPE-1) have the effect of improving the fatigue and leukopenia during radiotherapy. So the
      investigators designed this double blind and controlled trial to evaluate whether TPE-1 have
      the effects for leukopenia and cancer-related fatigue in breast cancer patients with
      radiotherapy. From our initial observation for 2 years, TPE-1 is safety. The study is also
      designed to evaluate the safety when patients taking this formula.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      TPE-1 is designed according to TCM concept. It is not anti-cancer directly, it is enhancing
      the Qi flow and immunity of breast cancer when they are just finishing chemotherapy and on
      going radiotherapy. Many Chinese population will seeking Chinese herbal medicine under the
      same condition.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the % change of white blood cell(WBC) count</measure>
    <time_frame>6 weeks</time_frame>
    <description>WBC will be checked before taking TPE ans after taking TPE-1.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin (Hb)</measure>
    <time_frame>6 weeks</time_frame>
    <description>The Hb will be checked before and after kaking TPE-1</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Radiotherapy</condition>
  <condition>Chinese Herbal Medicine</condition>
  <arm_group>
    <arm_group_label>herbal A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>dilute of (TPE-1) decoction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>herbal B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TPE-1 decoction (100 ml)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chinese herbal medicine decoction</intervention_name>
    <description>100 ml /Qd for 6 weeks(42 days)</description>
    <arm_group_label>herbal A</arm_group_label>
    <arm_group_label>herbal B</arm_group_label>
    <other_name>TPE-1</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  breast cancer

          -  age between 18 to 70 yrs

          -  finished chemotherapy (adriamycin ), will receiving radiotherapy

          -  Chinese population

          -  KP$ between 40-100

          -  ECOG &lt; 2

          -  WBC &gt;4X10(9)ÔºèL and Hb &gt; 10g/dl

          -  Assigned informed concent.

        Exclusion Criteria:

          -  receiving operation during 14 days

          -  blood transfusion during one month.

          -  ALT &gt;100mg/dL

          -  Creatinine &gt;2.0mg/dL

          -  Total bilirubin &gt;2.0mg/dL

          -  Infection

          -  prolation

          -  Taking anti-seizure , psychological drugs or any drugs not suitable patients

          -  AIDS or any disease diagnosed by physician and not suitable patients.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shuang Ho Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>886</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2010</study_first_submitted>
  <study_first_submitted_qc>June 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2010</study_first_posted>
  <last_update_submitted>May 28, 2014</last_update_submitted>
  <last_update_submitted_qc>May 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei City Hospital</investigator_affiliation>
    <investigator_full_name>Chung-Hua Hsu</investigator_full_name>
    <investigator_title>vice superintendent</investigator_title>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>Chinese herbal medicine</keyword>
  <keyword>TPE-1</keyword>
  <keyword>Leukopenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Leukopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

